Paige
Digital-pathology AI company, now part of Tempus, whose Alba co-pilot brings pathology, radiology and clinical data into one AI interface and whose diagnostic suites and foundation models are licensed to labs and life-sciences customers.
Regulatory filing · 7 Nov 2026Product
Selected offerings — the AI products recorded here, not the vendor's full catalogue.
-
Pathology co-pilot that combines pathology, radiology and clinical data in one AI-powered interface for pathologists, oncologists and clinicians; currently in beta and available by trial request.
Similar products 33
No sourced competitor yet: no filing, vendor document or measured-market report read so far names a rival for this company, so none is asserted. The companies below are the closest by what their products do.
Closest alternatives are pairs a vendor page itself compares. Similar products are matched from what each product does; nothing in that group is asserted as a rivalry.
Sources
- Total funding
-
Pages read for this record state no funding total. Tried the home and about pages..
- Valuation
-
Pages read for this record state no valuation. Tried the home and about pages..
- Founded
-
Pages read for this record state no founding year. Tried the home and about pages..
- Public listing
-
No listing on the pages read; a subsidiary of Tempus AI.
- Status
-
Regulatory filing · 7 Nov 2026
Tempus AI's 10-Q: "On August 22, 2025, or the Paige Closing Date, we completed our acquisition, or the Paige Acquisition, of Paige.AI, Inc." The domain still resolves to its own page naming Paige AI, Inc. and its own products, so it keeps an ordinary card with status acquired.
- Description
-
Official documentation · 7 Nov 2026
Home page banner "Paige, now a Tempus company"; Alba described as "a pathology co-pilot designed to transform the way pathologists, oncologists and clinicians' work."
Something wrong here? Send a correction — quote this company id: paige-ai.